APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Vertebroplasty and Kyphoplasty Devices

Vertebroplasty & Kyphoplasty are minimally invasive, image guided surgical procedures performed to treat the Vertebral Compression Fracture (VCF). VCFs can lead to back pain, reduced physical activity, depression, loss of independence, decreased lung capacity, and difficulty sleeping. Bone cement is injected into the back bone (vertebra) to provide support to the broken bone. Due to osteoporosis, vascular malformatins or, less commonly, cancer fractures can be caused in the vertebra. Vertebroplasty & Kyphoplasty help the patient to regain the functional abilities and avoid further vertebral collapse. Kyphoplasty is an advanced version of Vertebroplasty which can stabilize the fracture, restore heights and reduce deformities. The report studies the vertebroplasty and kyphoplasty devices market.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Vertebroplasty & Kyphoplasty are minimally invasive, image guided surgical procedures performed to treat the Vertebral Compression Fracture (VCF). VCFs can lead to back pain, reduced physical activity, depression, loss of independence, decreased lung capacity, and difficulty sleeping. Bone cement is injected into the back bone (vertebra) to provide support to the broken bone. Due to osteoporosis, vascular malformatins or, less commonly, cancer fractures can be caused in the vertebra. Vertebroplasty & Kyphoplasty help the patient to regain the functional abilities and avoid further vertebral collapse. Kyphoplasty is an advanced version of Vertebroplasty which can stabilize the fracture, restore heights and reduce deformities. The report studies the vertebroplasty and kyphoplasty devices market.

Selected research

Market Outlook & Growth Opportunities

Global Vertebroplasty and Kyphoplasty Devices Market Outlook and Growth Opportunities 2026

Report ID 17392588049 January 2026199 pages

Choose your research edition.

Industry ResearchVertebroplasty and Kyphoplasty Devices Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Vertebroplasty and Kyphoplasty Devices Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Vertebroplasty and Kyphoplasty Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vertebroplasty and Kyphoplasty Devices Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Vertebroplasty and Kyphoplasty Devices Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

Vertebroplasty & Kyphoplasty are minimally invasive, image guided surgical procedures performed to treat the Vertebral Compression Fracture (VCF). VCFs can lead to back pain, reduced physical activity, depression, loss of independence, decreased lung capacity, and difficulty sleeping. Bone cement is injected into the back bone (vertebra) to provide support to the broken bone. Due to osteoporosis, vascular malformatins or, less commonly, cancer fractures can be caused in the vertebra. Vertebroplasty & Kyphoplasty help the patient to regain the functional abilities and avoid further vertebral collapse. Kyphoplasty is an advanced version of Vertebroplasty which can stabilize the fracture, restore heights and reduce deformities. The report studies the vertebroplasty and kyphoplasty devices market.

Global Vertebroplasty and Kyphoplasty Devices key players include Medtronic, Stryker, J&J (Depuy Synthes), Globus Medical, Merit Medical, etc. Global top five manufacturers hold a share about 85%. North America is the largest market, with a share about 55%, followed by Asia-Pacific, with a share about 25 percent. In terms of product, Kyphoplasty is the largest segment, with a share about 80%. And in terms of application, the largest application is Hospital, followed by Ambulatory Surgery Center, etc.

This report provides an overview of the global Vertebroplasty and Kyphoplasty Devices market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Vertebroplasty and Kyphoplasty Devices and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Vertebroplasty and Kyphoplasty Devices sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Vertebroplasty and Kyphoplasty Devices market size, projected growth trends, production technologies, key applications, and end-use industries.

Vertebroplasty and Kyphoplasty Devices Segment by Company

Medtronic

Stryker

J&J (Depuy Synthes)

Globus Medical

Merit Medical

Kinetic Medical

Benvenue

Spine Wave

Teknimed

Vertebroplasty and Kyphoplasty Devices Segment by Type

Vertebroplasty

Kyphoplasty

Vertebroplasty and Kyphoplasty Devices Segment by Application

Hospital

Ambulatory Surgery Center

Others

Vertebroplasty and Kyphoplasty Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Vertebroplasty and Kyphoplasty Devices status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Vertebroplasty and Kyphoplasty Devices market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Vertebroplasty and Kyphoplasty Devices significant trends, drivers, influence factors in global and regions.

6. To analyze Vertebroplasty and Kyphoplasty Devices competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vertebroplasty and Kyphoplasty Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vertebroplasty and Kyphoplasty Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vertebroplasty and Kyphoplasty Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Vertebroplasty and Kyphoplasty Devices market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Vertebroplasty and Kyphoplasty Devices industry.

Chapter 3: Detailed analysis of Vertebroplasty and Kyphoplasty Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Vertebroplasty and Kyphoplasty Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Vertebroplasty and Kyphoplasty Devices in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Vertebroplasty and Kyphoplasty Devices Industry Trends Table 2. Vertebroplasty and Kyphoplasty Devices Industry Drivers Table 3. Vertebroplasty and Kyphoplasty Devices Industry Opportunities and Challenges Table 4. Vertebroplasty and Kyphoplasty Devices Industry Restraints Table 5. Global Vertebroplasty and Kyphoplasty Devices Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Vertebroplasty and Kyphoplasty Devices Revenue Share by Company (2021-2026) Table 7. Global Vertebroplasty and Kyphoplasty Devices Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Vertebroplasty and Kyphoplasty Devices Sales Volume Share by Company (2021-2026) Table 9. Global Vertebroplasty and Kyphoplasty Devices Average Price (USD/Unit) of Company (2021-2026) Table 10. Global Vertebroplasty and Kyphoplasty Devices Company Ranking, (2024-2026) & (USD Million) Table 11. Global Vertebroplasty and Kyphoplasty Devices Key Company Manufacturing Base & Headquarters Table 12. Global Vertebroplasty and Kyphoplasty Devices Company, Product Type & Application Table 13. Global Vertebroplasty and Kyphoplasty Devices Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Vertebroplasty and Kyphoplasty Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Vertebroplasty Table 18. Significant Companies of Kyphoplasty Table 19. Global Vertebroplasty and Kyphoplasty Devices Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Vertebroplasty and Kyphoplasty Devices Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Vertebroplasty and Kyphoplasty Devices Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Vertebroplasty and Kyphoplasty Devices Sales Volume Share by Type (2021-2026) Table 23. Global Vertebroplasty and Kyphoplasty Devices Sales Volume Share by Type (2027-2032) Table 24. Global Vertebroplasty and Kyphoplasty Devices Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Vertebroplasty and Kyphoplasty Devices Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Vertebroplasty and Kyphoplasty Devices Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type (2021-2026) Table 28. Global Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Ambulatory Surgery Center Table 31. Significant Companies of Others Table 32. Global Vertebroplasty and Kyphoplasty Devices Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Vertebroplasty and Kyphoplasty Devices Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Vertebroplasty and Kyphoplasty Devices Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Vertebroplasty and Kyphoplasty Devices Sales Volume Share by Application (2021-2026) Table 36. Global Vertebroplasty and Kyphoplasty Devices Sales Volume Share by Application (2027-2032) Table 37. Global Vertebroplasty and Kyphoplasty Devices Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Vertebroplasty and Kyphoplasty Devices Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Vertebroplasty and Kyphoplasty Devices Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application (2021-2026) Table 41. Global Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application (2027-2032) Table 42. Global Vertebroplasty and Kyphoplasty Devices Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Vertebroplasty and Kyphoplasty Devices Sales by Region (2021-2026) & (K Units) Table 44. Global Vertebroplasty and Kyphoplasty Devices Sales Market Share by Region (2021-2026) Table 45. Global Vertebroplasty and Kyphoplasty Devices Sales by Region (2027-2032) & (K Units) Table 46. Global Vertebroplasty and Kyphoplasty Devices Sales Market Share by Region (2027-2032) Table 47. Global Vertebroplasty and Kyphoplasty Devices Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Vertebroplasty and Kyphoplasty Devices Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Vertebroplasty and Kyphoplasty Devices Sales Value Share by Region (2021-2026) Table 50. Global Vertebroplasty and Kyphoplasty Devices Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Vertebroplasty and Kyphoplasty Devices Sales Value Share by Region (2027-2032) Table 52. Global Vertebroplasty and Kyphoplasty Devices Market Average Price (USD/Unit) by Region (2021-2026) Table 53. Global Vertebroplasty and Kyphoplasty Devices Market Average Price (USD/Unit) by Region (2027-2032) Table 54. Global Vertebroplasty and Kyphoplasty Devices Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Vertebroplasty and Kyphoplasty Devices Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Vertebroplasty and Kyphoplasty Devices Sales by Country (2021-2026) & (K Units) Table 57. Global Vertebroplasty and Kyphoplasty Devices Sales Market Share by Country (2021-2026) Table 58. Global Vertebroplasty and Kyphoplasty Devices Sales by Country (2027-2032) & (K Units) Table 59. Global Vertebroplasty and Kyphoplasty Devices Sales Market Share by Country (2027-2032) Table 60. Global Vertebroplasty and Kyphoplasty Devices Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Vertebroplasty and Kyphoplasty Devices Sales Value Market Share by Country (2021-2026) Table 62. Global Vertebroplasty and Kyphoplasty Devices Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Vertebroplasty and Kyphoplasty Devices Sales Value Market Share by Country (2027-2032) Table 64. Medtronic Company Information Table 65. Medtronic Business Overview Table 66. Medtronic Vertebroplasty and Kyphoplasty Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 67. Medtronic Vertebroplasty and Kyphoplasty Devices Product Portfolio Table 68. Medtronic Recent Development Table 69. Stryker Company Information Table 70. Stryker Business Overview Table 71. Stryker Vertebroplasty and Kyphoplasty Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 72. Stryker Vertebroplasty and Kyphoplasty Devices Product Portfolio Table 73. Stryker Recent Development Table 74. J&J (Depuy Synthes) Company Information Table 75. J&J (Depuy Synthes) Business Overview Table 76. J&J (Depuy Synthes) Vertebroplasty and Kyphoplasty Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 77. J&J (Depuy Synthes) Vertebroplasty and Kyphoplasty Devices Product Portfolio Table 78. J&J (Depuy Synthes) Recent Development Table 79. Globus Medical Company Information Table 80. Globus Medical Business Overview Table 81. Globus Medical Vertebroplasty and Kyphoplasty Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 82. Globus Medical Vertebroplasty and Kyphoplasty Devices Product Portfolio Table 83. Globus Medical Recent Development Table 84. Merit Medical Company Information Table 85. Merit Medical Business Overview Table 86. Merit Medical Vertebroplasty and Kyphoplasty Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 87. Merit Medical Vertebroplasty and Kyphoplasty Devices Product Portfolio Table 88. Merit Medical Recent Development Table 89. Kinetic Medical Company Information Table 90. Kinetic Medical Business Overview Table 91. Kinetic Medical Vertebroplasty and Kyphoplasty Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 92. Kinetic Medical Vertebroplasty and Kyphoplasty Devices Product Portfolio Table 93. Kinetic Medical Recent Development Table 94. Benvenue Company Information Table 95. Benvenue Business Overview Table 96. Benvenue Vertebroplasty and Kyphoplasty Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 97. Benvenue Vertebroplasty and Kyphoplasty Devices Product Portfolio Table 98. Benvenue Recent Development Table 99. Spine Wave Company Information Table 100. Spine Wave Business Overview Table 101. Spine Wave Vertebroplasty and Kyphoplasty Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 102. Spine Wave Vertebroplasty and Kyphoplasty Devices Product Portfolio Table 103. Spine Wave Recent Development Table 104. Teknimed Company Information Table 105. Teknimed Business Overview Table 106. Teknimed Vertebroplasty and Kyphoplasty Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 107. Teknimed Vertebroplasty and Kyphoplasty Devices Product Portfolio Table 108. Teknimed Recent Development Table 109. Key Raw Materials Table 110. Raw Materials Key Suppliers Table 111. Vertebroplasty and Kyphoplasty Devices Distributors List Table 112. Vertebroplasty and Kyphoplasty Devices Customers List Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Vertebroplasty and Kyphoplasty Devices Product Image Figure 2. Global Vertebroplasty and Kyphoplasty Devices Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Vertebroplasty and Kyphoplasty Devices Sales Value (2021-2032) & (US$ Million) Figure 4. Global Vertebroplasty and Kyphoplasty Devices Sales (2021-2032) & (K Units) Figure 5. Global Vertebroplasty and Kyphoplasty Devices Sales Average Price (USD/Unit) & (2021-2032) Figure 6. Global Vertebroplasty and Kyphoplasty Devices Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Vertebroplasty Image Figure 10. Kyphoplasty Image Figure 11. Global Vertebroplasty and Kyphoplasty Devices Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Vertebroplasty and Kyphoplasty Devices Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Vertebroplasty and Kyphoplasty Devices Sales Volume Share by Type (2021-2032) Figure 14. Global Vertebroplasty and Kyphoplasty Devices Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Vertebroplasty and Kyphoplasty Devices Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Ambulatory Surgery Center Image Figure 19. Others Image Figure 20. Global Vertebroplasty and Kyphoplasty Devices Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Vertebroplasty and Kyphoplasty Devices Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Vertebroplasty and Kyphoplasty Devices Sales Volume Share by Application (2021-2032) Figure 23. Global Vertebroplasty and Kyphoplasty Devices Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Vertebroplasty and Kyphoplasty Devices Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application (2021-2032) Figure 26. Global Vertebroplasty and Kyphoplasty Devices Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Vertebroplasty and Kyphoplasty Devices Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Vertebroplasty and Kyphoplasty Devices Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Vertebroplasty and Kyphoplasty Devices Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Vertebroplasty and Kyphoplasty Devices Sales Value (2021-2032) & (US$ Million) Figure 31. North America Vertebroplasty and Kyphoplasty Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Vertebroplasty and Kyphoplasty Devices Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Vertebroplasty and Kyphoplasty Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Vertebroplasty and Kyphoplasty Devices Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Vertebroplasty and Kyphoplasty Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Vertebroplasty and Kyphoplasty Devices Sales Value (2021-2032) & (US$ Million) Figure 37. South America Vertebroplasty and Kyphoplasty Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Vertebroplasty and Kyphoplasty Devices Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Vertebroplasty and Kyphoplasty Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Vertebroplasty and Kyphoplasty Devices Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Vertebroplasty and Kyphoplasty Devices Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Vertebroplasty
  • Kyphoplasty
Applications
  • Hospital
  • Ambulatory Surgery Center
  • Others
Companies covered
  • Medtronic
  • Stryker
  • J&J (Depuy Synthes)
  • Globus Medical
  • Merit Medical
  • Kinetic Medical
  • Benvenue
  • Spine Wave
  • Teknimed

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Vertebroplasty and Kyphoplasty Devices Sales Value (2021-2032)
  4. 1.2.2 Global Vertebroplasty and Kyphoplasty Devices Sales Volume (2021-2032)
  5. 1.2.3 Global Vertebroplasty and Kyphoplasty Devices Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Vertebroplasty and Kyphoplasty Devices Market Dynamics
  1. 2.1 Vertebroplasty and Kyphoplasty Devices Industry Trends
  2. 2.2 Vertebroplasty and Kyphoplasty Devices Industry Drivers
  3. 2.3 Vertebroplasty and Kyphoplasty Devices Industry Opportunities and Challenges
  4. 2.4 Vertebroplasty and Kyphoplasty Devices Industry Restraints
3 Vertebroplasty and Kyphoplasty Devices Market by Company
  1. 3.1 Global Vertebroplasty and Kyphoplasty Devices Company Revenue Ranking in 2025
  2. 3.2 Global Vertebroplasty and Kyphoplasty Devices Revenue by Company (2021-2026)
  3. 3.3 Global Vertebroplasty and Kyphoplasty Devices Sales Volume by Company (2021-2026)
  4. 3.4 Global Vertebroplasty and Kyphoplasty Devices Average Price by Company (2021-2026)
  5. 3.5 Global Vertebroplasty and Kyphoplasty Devices Company Ranking (2024-2026)
  6. 3.6 Global Vertebroplasty and Kyphoplasty Devices Company Manufacturing Base and Headquarters
  7. 3.7 Global Vertebroplasty and Kyphoplasty Devices Company Product Type and Application
  8. 3.8 Global Vertebroplasty and Kyphoplasty Devices Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Vertebroplasty and Kyphoplasty Devices Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Vertebroplasty and Kyphoplasty Devices Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Vertebroplasty and Kyphoplasty Devices Market by Type
  1. 4.1 Vertebroplasty and Kyphoplasty Devices Type Introduction
  2. 4.1.1 Vertebroplasty
  3. 4.1.2 Kyphoplasty
  4. 4.2 Global Vertebroplasty and Kyphoplasty Devices Sales Volume by Type
  5. 4.2.1 Global Vertebroplasty and Kyphoplasty Devices Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Vertebroplasty and Kyphoplasty Devices Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Vertebroplasty and Kyphoplasty Devices Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Vertebroplasty and Kyphoplasty Devices Sales Value by Type
  9. 4.3.1 Global Vertebroplasty and Kyphoplasty Devices Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Vertebroplasty and Kyphoplasty Devices Sales Value by Type (2021-2032)
  11. 4.3.3 Global Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type (2021-2032)
5 Vertebroplasty and Kyphoplasty Devices Market by Application
  1. 5.1 Vertebroplasty and Kyphoplasty Devices Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Ambulatory Surgery Center
  4. 5.1.3 Others
  5. 5.2 Global Vertebroplasty and Kyphoplasty Devices Sales Volume by Application
  6. 5.2.1 Global Vertebroplasty and Kyphoplasty Devices Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Vertebroplasty and Kyphoplasty Devices Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Vertebroplasty and Kyphoplasty Devices Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Vertebroplasty and Kyphoplasty Devices Sales Value by Application
  10. 5.3.1 Global Vertebroplasty and Kyphoplasty Devices Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Vertebroplasty and Kyphoplasty Devices Sales Value by Application (2021-2032)
  12. 5.3.3 Global Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application (2021-2032)
6 Vertebroplasty and Kyphoplasty Devices Regional Sales and Value Analysis
  1. 6.1 Global Vertebroplasty and Kyphoplasty Devices Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Vertebroplasty and Kyphoplasty Devices Sales by Region (2021-2032)
  3. 6.2.1 Global Vertebroplasty and Kyphoplasty Devices Sales by Region: 2021-2026
  4. 6.2.2 Global Vertebroplasty and Kyphoplasty Devices Sales by Region (2027-2032)
  5. 6.3 Global Vertebroplasty and Kyphoplasty Devices Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Vertebroplasty and Kyphoplasty Devices Sales Value by Region (2021-2032)
  7. 6.4.1 Global Vertebroplasty and Kyphoplasty Devices Sales Value by Region: 2021-2026
  8. 6.4.2 Global Vertebroplasty and Kyphoplasty Devices Sales Value by Region (2027-2032)
  9. 6.5 Global Vertebroplasty and Kyphoplasty Devices Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Vertebroplasty and Kyphoplasty Devices Sales Value (2021-2032)
  12. 6.6.2 North America Vertebroplasty and Kyphoplasty Devices Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Vertebroplasty and Kyphoplasty Devices Sales Value (2021-2032)
  15. 6.7.2 Europe Vertebroplasty and Kyphoplasty Devices Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Vertebroplasty and Kyphoplasty Devices Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Vertebroplasty and Kyphoplasty Devices Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Vertebroplasty and Kyphoplasty Devices Sales Value (2021-2032)
  21. 6.9.2 South America Vertebroplasty and Kyphoplasty Devices Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Vertebroplasty and Kyphoplasty Devices Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Vertebroplasty and Kyphoplasty Devices Sales Value Share by Country, 2025 VS 2032
7 Vertebroplasty and Kyphoplasty Devices Country-level Sales and Value Analysis
  1. 7.1 Global Vertebroplasty and Kyphoplasty Devices Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Vertebroplasty and Kyphoplasty Devices Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Vertebroplasty and Kyphoplasty Devices Sales by Country (2021-2032)
  4. 7.3.1 Global Vertebroplasty and Kyphoplasty Devices Sales by Country (2021-2026)
  5. 7.3.2 Global Vertebroplasty and Kyphoplasty Devices Sales by Country (2027-2032)
  6. 7.4 Global Vertebroplasty and Kyphoplasty Devices Sales Value by Country (2021-2032)
  7. 7.4.1 Global Vertebroplasty and Kyphoplasty Devices Sales Value by Country (2021-2026)
  8. 7.4.2 Global Vertebroplasty and Kyphoplasty Devices Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Vertebroplasty and Kyphoplasty Devices Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Vertebroplasty and Kyphoplasty Devices Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Vertebroplasty and Kyphoplasty Devices Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Medtronic
  2. 8.1.1 Medtronic Company Information
  3. 8.1.2 Medtronic Business Overview
  4. 8.1.3 Medtronic Vertebroplasty and Kyphoplasty Devices Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Medtronic Vertebroplasty and Kyphoplasty Devices Product Portfolio
  6. 8.1.5 Medtronic Recent Developments
  7. 8.2 Stryker
  8. 8.2.1 Stryker Company Information
  9. 8.2.2 Stryker Business Overview
  10. 8.2.3 Stryker Vertebroplasty and Kyphoplasty Devices Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Stryker Vertebroplasty and Kyphoplasty Devices Product Portfolio
  12. 8.2.5 Stryker Recent Developments
  13. 8.3 J&J (Depuy Synthes)
  14. 8.3.1 J&J (Depuy Synthes) Company Information
  15. 8.3.2 J&J (Depuy Synthes) Business Overview
  16. 8.3.3 J&J (Depuy Synthes) Vertebroplasty and Kyphoplasty Devices Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 J&J (Depuy Synthes) Vertebroplasty and Kyphoplasty Devices Product Portfolio
  18. 8.3.5 J&J (Depuy Synthes) Recent Developments
  19. 8.4 Globus Medical
  20. 8.4.1 Globus Medical Company Information
  21. 8.4.2 Globus Medical Business Overview
  22. 8.4.3 Globus Medical Vertebroplasty and Kyphoplasty Devices Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Globus Medical Vertebroplasty and Kyphoplasty Devices Product Portfolio
  24. 8.4.5 Globus Medical Recent Developments
  25. 8.5 Merit Medical
  26. 8.5.1 Merit Medical Company Information
  27. 8.5.2 Merit Medical Business Overview
  28. 8.5.3 Merit Medical Vertebroplasty and Kyphoplasty Devices Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Merit Medical Vertebroplasty and Kyphoplasty Devices Product Portfolio
  30. 8.5.5 Merit Medical Recent Developments
  31. 8.6 Kinetic Medical
  32. 8.6.1 Kinetic Medical Company Information
  33. 8.6.2 Kinetic Medical Business Overview
  34. 8.6.3 Kinetic Medical Vertebroplasty and Kyphoplasty Devices Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Kinetic Medical Vertebroplasty and Kyphoplasty Devices Product Portfolio
  36. 8.6.5 Kinetic Medical Recent Developments
  37. 8.7 Benvenue
  38. 8.7.1 Benvenue Company Information
  39. 8.7.2 Benvenue Business Overview
  40. 8.7.3 Benvenue Vertebroplasty and Kyphoplasty Devices Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Benvenue Vertebroplasty and Kyphoplasty Devices Product Portfolio
  42. 8.7.5 Benvenue Recent Developments
  43. 8.8 Spine Wave
  44. 8.8.1 Spine Wave Company Information
  45. 8.8.2 Spine Wave Business Overview
  46. 8.8.3 Spine Wave Vertebroplasty and Kyphoplasty Devices Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Spine Wave Vertebroplasty and Kyphoplasty Devices Product Portfolio
  48. 8.8.5 Spine Wave Recent Developments
  49. 8.9 Teknimed
  50. 8.9.1 Teknimed Company Information
  51. 8.9.2 Teknimed Business Overview
  52. 8.9.3 Teknimed Vertebroplasty and Kyphoplasty Devices Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Teknimed Vertebroplasty and Kyphoplasty Devices Product Portfolio
  54. 8.9.5 Teknimed Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Vertebroplasty and Kyphoplasty Devices Value Chain Analysis
  2. 9.1.1 Vertebroplasty and Kyphoplasty Devices Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Vertebroplasty and Kyphoplasty Devices Sales Mode & Process
  6. 9.2 Vertebroplasty and Kyphoplasty Devices Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Vertebroplasty and Kyphoplasty Devices Distributors
  9. 9.2.3 Vertebroplasty and Kyphoplasty Devices Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst